摘要
目的 :以该室克隆的PCRⅡ hCGβ载体为模板 ,亚克隆到表达载体PG5中使hCGβ基因在大肠杆菌中进行高效表达。方法 :改变部分hCGβ序列 ,得到重组PG5 hCGβ载体 ,经序列分析证明 ,再转化到表达菌BL2 1中表达 ,所得包涵体经过柱纯化 ,复性 ,免疫发光分析和动物试验测定其活性。结果 :经SDS PAGE电泳在 18kD左右有一条明显的新增蛋白带 ,与预期的分子量相符 ,并用Western印迹证实 ,rhCGβ约占菌体总蛋白的 10 % ,活性为 7.8U mg。 结论 :重组hCGβ在大肠杆菌中获得了较高水平的表达。且经复性后有较高的免疫活性和生物活性。
Objective:Using the previously cloned vector PCRⅡ/hCGβ as the template,subclone the aimed gene into expression vector PG5,make hCGβ expressed efficiently in E.coli.Methods:Several neucleotides of hCGβ in recombinant PCRⅡ/hCGβ were altered through PCR method,then the modified hCGβ was inserted into PG5,proved by sequencing analysis,and transformed E.coli host strain BL21.The expressed inclusion body was extracted,dissolved,and refolded.Its immunological and physiological activities were measured by immunoflurescent assay and animal experiments respectively.Results:The results of SDS PAGE electrophoresis and western blot demonstrated that the IPTG induced bacteria expressed an extra band of 18 kD in comparison with the uninduced ones.The expression level was more than 10% of the total cell lysate,and the immunological activity,7.8 U/ml.Conclusion:The recombinant PG5/hCGβ was effeciently expressed in E.coli,and the recombinant protein has high immunological and physiological activities.
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2000年第8期415-417,共3页
Chinese Journal of Immunology
基金
宁波市自然科学基金!资助项目 (编号 982 7)